Objective: The aim of study was to ensure supply of safe and efficient blood transfusion to patient and to prevent Transfusion Transmitted Diseases. Methods: The present study included data of routine monthly analysis of whole blood and blood components which was collected from archives of blood bank from the period of 1st January 2018 to 31st December 2019. Data was collected for the above mentioned period in which blood was collected from 2520 healthy donors in sterile single, double or triple blood bags with anticoagulant Citrate Phosphate Dextrose Adenine 1 (CPDA 1) after taking written consent.